Project 2 (P2). Genetic modifiers of atherosclerosis and foam cell lipid droplet metabolism Jonathan Smith, Ph.D., Project Leader Project Summary/Abstract Heart disease is the number one killer of men and women in the United States. Although the incidence of cardiovascular disease deaths has declined, it still accounts for ~1 out of every 3 deaths. Coronary artery disease (CAD) due to atherosclerosis was responsible for most of these deaths. Despite increased knowledge about CAD risk factors and the availably of drugs to treat them, the CAD problem has not been solved. Large human genome wide association studies have identified many common genetic variants associated with CAD, but only a small fraction of the heritable risk has been discovered. Here we propose to perform mouse genetic and genomic studies to identify atherosclerosis modifier genes and genetic modifiers of foam cell lipid droplet metabolism, yielding insights into the mechanisms that regulate these pathways. These findings may lead to novel drug targets and therapies to prevent or treat CAD.
The first aim of the proposed studies involves identifying the responsible genes and genetic variation that give rise to the mouse atherosclerosis susceptibility loci on chromosomes 2 and 17, which we have recently independently replicated. Validation will be performed by allele replacement, the gold standard method to demonstrate a direct causal effect of genetic variation on a phenotype.
The second aim of the proposed studies involves the study of an intermediate phenotype that we discovered in atherosclerosis sensitive vs. resistant mice. We found that cholesterol ester stored in lipid droplets of macrophage foam cells is metabolized by autophagy with hydrolysis mediated by lysosomal acid lipase, such that the atherosclerosis sensitive strain has lower rates of flux through this pathway, implying that this pathway is atheroprotective. Thus, we propose to use genetic, genomic, and proteomic studies to identify the genetic variant responsible for this intermediate phenotype, and validate the causal genetic variant via allele replacement. Finally, we will probe whether the antiatherogenic effect of mTOR inhibitors in mice is mediated via an induction of foam cell autophagy.
Project 2 (P2). Project Narrative The proposed studies address a significant health concern, coronary artery disease, and will yield insight into the mechanisms that modify atherosclerosis susceptibility. The discovery of novel pathways and proteins that regulate atherosclerosis and foam cell cholesterol ester turnover offers hope for new modes of risk assessment, prevention, and therapy.
|Herjan, Tomasz; Hong, Lingzi; Bubenik, Jodi et al. (2018) IL-17-receptor-associated adaptor Act1 directly stabilizes mRNAs to mediate IL-17 inflammatory signaling. Nat Immunol 19:354-365|
|Robinet, Peggy; Milewicz, Dianna M; Cassis, Lisa A et al. (2018) Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies-Statement From ATVB Council. Arterioscler Thromb Vasc Biol 38:292-303|
|Zhang, Cun-Jin; Wang, Chenhui; Jiang, Meiling et al. (2018) Act1 is a negative regulator in T and B cells via direct inhibition of STAT3. Nat Commun 9:2745|
|Han, Juying; Enyindah-Asonye, Gospel; Lin, Feng et al. (2018) CD6 expression has no effect on atherosclerosis in apolipoprotein E-deficient mice. BMC Res Notes 11:229|
|Sarvestani, Samaneh K; Signs, Steven A; Lefebvre, Veronique et al. (2018) Cancer-predicting transcriptomic and epigenetic signatures revealed for ulcerative colitis in patient-derived epithelial organoids. Oncotarget 9:28717-28730|
|Arif, Abul; Yao, Peng; Terenzi, Fulvia et al. (2018) The GAIT translational control system. Wiley Interdiscip Rev RNA 9:|
|Hai, Qimin; Ritchey, Brian; Robinet, Peggy et al. (2018) Quantitative Trait Locus Mapping of Macrophage Cholesterol Metabolism and CRISPR/Cas9 Editing Implicate an ACAT1 Truncation as a Causal Modifier Variant. Arterioscler Thromb Vasc Biol 38:83-91|
|Eswarappa, Sandeep M; Potdar, Alka A; Sahoo, Sarthak et al. (2018) Metabolic origin of the fused aminoacyl-tRNA synthetase, glutamyl-prolyl-tRNA synthetase. J Biol Chem 293:19148-19156|
|Halawani, Dalia; Gogonea, Valentin; DiDonato, Joseph A et al. (2018) Structural control of caspase-generated glutamyl-tRNA synthetase by appended noncatalytic WHEP domains. J Biol Chem 293:8843-8860|
|Zhou, Hao; Bulek, Katarzyna; Li, Xiao et al. (2017) IRAK2 directs stimulus-dependent nuclear export of inflammatory mRNAs. Elife 6:|
Showing the most recent 10 out of 276 publications